Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Rosalind Advisors, Inc.
Form 13F · Q2 2026

Rosalind Advisors, Inc.

CIK 1622627Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$269M
Reported book value
35
Positions
11
Quarters on record
Top 50
Positions

Rosalind Advisors, Inc. — holdings

Top 29 positions of 35, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1DCTH Delcath Sys Inc3.3M+0.0%$42M15.4%
2FENC Fennec Pharmaceuticals Inc3.2M+9.6%$34M12.7%
3XERS Xeris Biopharma Holdings Inc2.9M−10.0%$23M8.6%
4SVRA Savara Inc3.2M−0.8%$20M7.3%
5VSTM Verastem Inc4.0M+86.4%$15M5.7%
6XFOR X4 Pharmaceuticals Inc3.2M+0.0%$15M5.6%
7EYPT Eyepoint Inc988,230−4.7%$14M5.2%
8HELP Cybin Inc2.0M+27.7%$13M4.8%
9VOR Vor Biopharma Inc648,600−7.3%$12M4.4%
10PCVX Vaxcyte Inc200,000−31.0%$12M4.3%
11MDWD Mediwound Ltd749,054+0.0%$11M4.1%
12CLDX Celldex Therapeutics Inc New200,000−39.4%$7M2.8%
13BCRX Biocryst Pharmaceuticals Inc721,504−21.8%$7M2.7%
14PROF Profound Med Corp828,118+0.0%$6M2.0%
15TLPH Talphera Inc5.2M+54.1%$5M2.0%
16AVIR Atea Pharmaceuticals Inc1.1M−8.6%$5M1.8%
17MYO Myomo Inc3.6M−5.4%$4M1.4%
18OVID Ovid Therapeutics Inc1.1M+0.0%$3M1.1%
19NRXS Neuraxis Inc508,055+77.6%$3M1.1%
20ABVX Abivax Sa20,869—$3M1.0%
21NSPR Inspiremd Inc3.9M+0.0%$3M1.0%
22RGNT Regentis Biomaterials Ltd701,685+179.0%$2M0.9%
23PYPD Polypid Ltd389,455−34.9%$2M0.7%
24BFRI Biofrontera Inc1.3M+9.6%$1M0.4%
25KURA Kura Oncology Inc100,000+0.0%$1M0.4%
26SPRB Spruce Biosciences Inc20,000—$1M0.4%
27AQST Aquestive Therapeutics Inc250,000+0.0%$1M0.4%
28OKUR Onkure Therapeutics Inc150,000−66.2%$684,0000.3%
29PEPG Pepgen Inc350,000—$630,0000.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.